ArticleNature medicine2020

Safety and feasibility of anti-CD19 CAR T cells with fully human binding domains in patients with B-cell lymphoma.

Jennifer N Brudno et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.